LNWWM
GMAB icon

Laird Norton Wetherby Wealth Management’s Genmab GMAB Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$229K Buy
+7,475
New +$182K 0.01% 843
2024
Q4 		$286K Buy
13,711
+2,023
+17% +$44.4K 0.01% 713
2024
Q3 		$285K Sell
11,688
-1,123
-9% -$30K 0.01% 750
2024
Q2 		$322K Sell
12,811
-1,334
-9% -$37.8K 0.02% 688
2024
Q1 		$423K Sell
14,145
-3,168
-18% -$93.1K 0.02% 614
2023
Q4 		$551K Buy
17,313
+197
+1% +$6.18K 0.03% 520
2023
Q3 		$604K Buy
17,116
+1,177
+7% +$44.9K 0.03% 457
2023
Q2 		$606K Buy
15,939
+88
+0.6% +$3.51K 0.03% 471
2023
Q1 		$599K Sell
15,851
-855
-5% -$32.9K 0.04% 474
2022
Q4 		$708K Buy
16,706
+378
+2% +$15.6K 0.05% 405
2022
Q3 		$525K Buy
16,328
+4,253
+35% +$149K 0.04% 474
2022
Q2 		$393K Sell
12,075
-3,339
-22% -$108K 0.03% 576
2022
Q1 		$558K Buy
15,414
+1,025
+7% +$35.2K 0.03% 489
2021
Q4 		$569K Buy
14,389
+358
+3% +$14.9K 0.03% 473
2021
Q3 		$613K Buy
14,031
+1,073
+8% +$48.2K 0.04% 439
2021
Q2 		$529K Sell
12,958
-270
-2% -$10.4K 0.03% 490
2021
Q1 		$434K Sell
13,228
-576
-4% -$21.7K 0.03% 481
2020
Q4 		$562K Sell
13,804
-949
-6% -$35.5K 0.04% 433
2020
Q3 		$540K Buy
14,753
+3,340
+29% +$121K 0.05% 360
2020
Q2 		$387K Buy
+11,413
New +$311K 0.04% 421
2020
Q1 		– Sell
-10,092
Closed -$225K – 712
2019
Q4 		$225K Buy
+10,092
New +$220K 0.02% 631

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's GMAB Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management opened a new position in Genmab (GMAB) in Q3 2025: 7,475 shares worth $229K. The stake represents 0.01% of the portfolio and ranks #843 among its holdings. This is a return to the name: Laird Norton Wetherby Wealth Management previously reported a position in GMAB as recently as Q4 2024.

Laird Norton Wetherby Wealth Management first reported a position in GMAB in Q4 2019 and has held it in 21 quarters since. The position peaked at $708K in Q4 2022. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 7,475 shares of Genmab worth $229K as of Q3 2025.
  • Genmab was a new Laird Norton Wetherby Wealth Management position in Q3 2025.
  • Genmab made up 0.01% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #843 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in Genmab in Q4 2019 and has held it in 21 quarters since.
  • Laird Norton Wetherby Wealth Management's Genmab position peaked at $708K in Q4 2022.
  • 252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.